GlaxoWellcome

GSK is a global biopharmaceutical company headquartered in London, formed through the landmark merger of Glaxo Wellcome and SmithKline Beecham in 2000. The company focuses on four main therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. GSK is a world leader in vaccines, producing a wide range of products including Shingrix for shingles and Arexvy for respiratory syncytial virus. Following the 2022 demerger of its consumer healthcare business, Haleon, GSK has pivoted to become a pure-play biopharma entity with a heavy emphasis on R&D and specialty medicines. The company leverages advanced technologies in human genetics and genomics to drive its innovation pipeline. GSK's commercial portfolio is supported by a global manufacturing network and significant presence in both developed and emerging markets.